Genprex, Inc. Quarterly Costs and Expenses in USD from Q3 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Genprex, Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2016 to Q2 2024.
  • Genprex, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $6.52M, a 18.9% decline year-over-year.
  • Genprex, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $26.3M, a 12.5% decline year-over-year.
  • Genprex, Inc. annual Costs and Expenses for 2023 was $31.1M, a 30.4% increase from 2022.
  • Genprex, Inc. annual Costs and Expenses for 2022 was $23.8M, a 15.3% increase from 2021.
  • Genprex, Inc. annual Costs and Expenses for 2021 was $20.7M, a 15.1% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $26.3M $6.52M -$1.52M -18.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $27.8M $6M -$3.27M -35.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $31.1M $5.99M -$592K -9.01% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $31.7M $7.79M +$1.62M +26.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $30.1M $8.04M +$2.27M +39.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $27.8M $9.26M +$3.95M +74.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $23.8M $6.58M -$1.35M -17.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $25.2M $6.17M +$2.73M +79.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $22.5M $5.77M +$1.78M +44.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2022 $20.7M $5.31M $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 $20.7M $7.93M +$2.7M +51.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $18M $3.44M +$661K +23.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $17.3M $3.99M -$391K -8.93% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $17.7M $5.31M -$266K -4.76% Jan 1, 2021 Mar 31, 2021 10-K 2023-03-31
Q4 2020 $18M $5.23M +$2.8M +115% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $15.2M $2.78M +$397K +16.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $14.8M $4.38M +$674K +18.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $14.1M $5.58M +$3.41M +157% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $10.7M $2.43M -$1.02M -29.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-26
Q3 2019 $11.7M $2.38M +$183K +8.35% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $11.5M $3.7M -$2.33M -38.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $13.8M $2.17M +$1.48M +216% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $12.4M $3.44M +$2.78M +418% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 $9.58M $2.2M +$1.48M +207% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $8.1M $6.04M +$4.85M +411% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $3.25M $687K -$64.7K -8.61% Jan 1, 2018 Mar 31, 2018 10-Q/A 2019-05-20
Q4 2017 $3.31M $665K Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 $715K -$4.74K -0.66% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $1.18M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $751K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q3 2016 $720K Jul 1, 2016 Sep 30, 2016 10-Q/A 2017-12-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.